Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Cancer
|
May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation
H M Lazarus, M R Gottfried, R H Herzig, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 6, 2020
Prospective multicentre observational study assessing the tolerance and perception of patients using the Liquick Base catheter with an Ergothan tip
X Gamé, L Gania, B Perrouin-Verbe, et al.
Blood
|
March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
A F List, C S Spier, T M Grogan, et al.
Nature Biomedical Engineering
|
June 8, 2023
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
Angela Q Zhang, Alexander Hostetler, Laura E Chen, et al.
Nature Communications
|
December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer
Sangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Bone Marrow Transplantation
|
May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
S N Wolff, J Fay, D Stevens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
R H Collins, O Shpilberg, W R Drobyski, et al.
Leukemia & Lymphoma
|
October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group
D R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation
|
April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Z S Pavletic, E R Arrowsmith, P J Bierman, et al.
Bone Marrow Transplantation
|
August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
D J Winston, J H Antin, S N Wolff, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Cancer
|
May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation
H M Lazarus, M R Gottfried, R H Herzig, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 6, 2020
Prospective multicentre observational study assessing the tolerance and perception of patients using the Liquick Base catheter with an Ergothan tip
X Gamé, L Gania, B Perrouin-Verbe, et al.
Blood
|
March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
A F List, C S Spier, T M Grogan, et al.
Nature Biomedical Engineering
|
June 8, 2023
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
Angela Q Zhang, Alexander Hostetler, Laura E Chen, et al.
Nature Communications
|
December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer
Sangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Bone Marrow Transplantation
|
May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
S N Wolff, J Fay, D Stevens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
R H Collins, O Shpilberg, W R Drobyski, et al.
Leukemia & Lymphoma
|
October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group
D R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation
|
April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Z S Pavletic, E R Arrowsmith, P J Bierman, et al.
Bone Marrow Transplantation
|
August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
D J Winston, J H Antin, S N Wolff, et al.
Page
of 18